Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. - Wikidata - wikimedia - TriplyDB

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

http://www.wikidata.org/entity/Q34056699

about

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 A comparison of netilmicin and tobramycin therapy in patients with renal impairment Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicity Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients Expression of the heat shock protein 47 in gentamicin-treated rat kidneys Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.Aminoglycosides: nephrotoxicity The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies Minimisation of aminoglycoside toxicity in patients with cystic fibrosis The incidence and prognostic significance of acute kidney injury.Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats.Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation.Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections.Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters.Gentamicin pharmacokinetics, nephrotoxicity, and prediction of mortality in febrile neutropenic patients Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.A prospective randomized trial of imipenem-cilastatin versus clindamycin/tobramycin in the treatment of intra-abdominal and pelvic infections Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.Predicted tissue accumulation of netilmicin in patients.Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections.Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates Two-compartment comparison of gentamicin and tobramycin in normal volunteers Just the berries: Nephrotoxic drugs.Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.Evidence That Antibiotics Bind to Human Mitochondrial Ribosomal RNA Has Implications for Aminoglycoside Toxicity.A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury Drug-induced acute kidney injury in children The 6R's of drug induced nephrotoxicity Antibiotic blood concentrations in patients successfully treated with tobramycin.Drug-induced renal toxicity. Help in recognizing offending agents.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).

P2860

Q24671879-D7325111-3CAF-4854-827E-971C41C51A38 Q28316869-77C2CFA1-93D2-42B0-BCD5-B304B88DD6DA Q28359459-3FBF39C8-ECE4-4556-A1C3-197C69370448 Q28361867-87ED9074-1743-4526-999F-D238FA553E0E Q28361967-66ADBD74-54C4-4EFA-828D-2A5715CA614D Q28362686-4E43A9FA-F45A-4B9D-BB2D-8BC7907E1F92 Q28366502-999D62F9-8650-4631-9A81-91A94D44D6F0 Q28367851-47C3F538-0D0E-4BEB-A546-B2661A9EC21D Q28368944-DFEB289D-B4FC-4A8C-985B-611D135D69EC Q28379292-338DC9C5-A164-4F97-8424-7A7D568B5EF5 Q28540814-076F6F0B-4E5A-49B1-B9B8-CB34B1DB5CF3 Q33605648-E240221B-A531-41E9-ACFF-FD8924D901C5 Q33686940-587A8382-A130-47CC-AA41-FC058C0487BE Q33775991-E7FB6245-EA4E-4BDB-B562-DFBF7C4E7735 Q34523413-80391693-1E4F-477A-AFCD-C796927CC80B Q34874579-DEDDFB45-F895-4A3D-996C-C91A21931CE7 Q35254820-1C3AD91E-4BE9-46EB-AF2E-BA2EF7AC32BB Q35259843-A479B345-8092-47C0-AD5F-E226148070BB Q35318425-BE5EAA85-470B-4DBC-B94C-CD1092BDD12D Q35341106-4C00DF1C-F25B-4B04-8A9F-1F653080EBFA Q35359054-61433A0C-9B6B-4896-A1CA-FC411494104C Q35574202-27CD8048-8290-496F-8750-A4D60B1AD396 Q35642347-08E308D7-D18B-47BE-9000-BCC8D0FC0C98 Q35649774-73FFAF69-8762-4D88-828E-71BA8F634657 Q35669927-EB19A8FD-EEC8-451D-BF32-EB4A04D31AFF Q35672495-F3D98FBF-ED03-4075-AC61-88A16759BE83 Q35674282-EFFEBDDC-9BC3-4DEF-85D7-A7640B280066 Q35754903-54CF1C17-48A7-4607-9A03-03632C5D4807 Q35755215-6AFAC407-7155-45F2-836C-F4336DD9C396 Q35755665-9A995480-58B1-4620-96D3-085A3EC95A36 Q35761185-42F86F17-2C88-4337-A883-F4055313D75B Q35788876-5C5E7B8B-BAD9-4807-BE87-8624FDC7BB06 Q35806154-291073F3-85FE-478D-9BD8-CD5DC189E329 Q35905403-DBC48964-3CCD-41A5-B482-32A9D4ED44AF Q36125404-E8B53CBF-EDF2-4E13-896A-E882E2F7DA72 Q36125552-6533B7CF-442B-4B6E-9522-FD922F884FEC Q36333140-CB2C79A1-A058-4D74-A4F0-1E30D685983E Q36716820-F0D6C333-452B-4EA1-B2C5-38F6B0AF4996 Q37213753-D212AA66-3E10-4F3C-B299-A22616AEB182 Q38070006-BBBC5076-EDE0-4617-B2F9-CABEC307B846

P2860

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

http://www.wikidata.org/entity/Q34056699

description

1980 nî lūn-bûn

@nan

1980 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1980 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1980年の論文

@ja

1980年論文

@yue

1980年論文

@zh-hant

1980年論文

@zh-hk

1980年論文

@zh-mo

1980年論文

@zh-tw

1980年论文

@wuu

name

Double-blind comparison of the ...... of gentamicin and tobramycin.

@ast

Double-blind comparison of the ...... of gentamicin and tobramycin.

@en

Double-blind comparison of the ...... of gentamicin and tobramycin.

@nl

type

label

Double-blind comparison of the ...... of gentamicin and tobramycin.

@ast

Double-blind comparison of the ...... of gentamicin and tobramycin.

@en

Double-blind comparison of the ...... of gentamicin and tobramycin.

@nl

prefLabel

Double-blind comparison of the ...... of gentamicin and tobramycin.

@ast

Double-blind comparison of the ...... of gentamicin and tobramycin.

@en

Double-blind comparison of the ...... of gentamicin and tobramycin.

@nl

P1433

Q34056699-A7461446-8B5C-4AE3-9CB2-901F8432D1E5

P1476

Q34056699-92F9E3A2-08FD-4C6D-A0D4-036FCE80EF44

P2093

Q34056699-183CF297-85F1-4AA6-9502-848667D8DB45

Q34056699-27F21DA8-0DD9-4F6B-A00E-136D998CC491

Q34056699-3AE6FAC3-CFA4-440E-B7B9-EB30046B515E

Q34056699-8D692BD5-866D-4E03-81DD-4DABEEC25A35

Q34056699-C3CF1CDA-EA95-4FE0-9F53-B644E19AA5EE

Q34056699-C9D02D80-BBC3-4CEF-8DE5-E1291372B3FE

Q34056699-EFCB421B-5361-49C4-BA94-88341A82E079

P304

Q34056699-3FD6865D-9313-4044-AE22-411671F5956C

P31

Q34056699-10C34FAC-D74E-4267-A35C-D239036BE472

P356

Q34056699-101EC284-0CF7-4B49-959C-37160D9B91F6

P407

Q34056699-96ACCC0D-3439-483A-B92C-E21F5F4EE8DB

P433

Q34056699-41D79AC5-3569-41D0-8E56-6B50EE4C26A2

P478

Q34056699-1066C5A6-1C48-4961-B503-C082CB992CEE

P577

Q34056699-35807045-E25E-4EE0-BE94-7FEEAE96E026

P698

Q34056699-1F748AD1-7C73-471D-9E65-1F821EBD543B

P921

Q34056699-E61F4EE2-BB1A-46A7-9B1E-7774451FC740

P356

NEJM198005153022002

P1433

The New England Journal of Medicine

P1476

Double-blind comparison of the ...... of gentamicin and tobramycin.

@en

P2093

Hellmann DB

http://www.w3.org/2001/XMLSchema#string

Laskin OL

http://www.w3.org/2001/XMLSchema#string

Lietman PS

http://www.w3.org/2001/XMLSchema#string

Lipsky JJ

http://www.w3.org/2001/XMLSchema#string

Longstreth J

http://www.w3.org/2001/XMLSchema#string

Mellits ED

http://www.w3.org/2001/XMLSchema#string

Smith CR

http://www.w3.org/2001/XMLSchema#string

P304

1106-1109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM198005153022002

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

302

http://www.w3.org/2001/XMLSchema#string

P577

1980-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6988713

http://www.w3.org/2001/XMLSchema#string

P921